Mesoblast Limited
Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant, unmet medical needs. The...load more
Mesoblast Limited's Basic Information
Industry
Headquarters
Melbourne, Victoria, Australia
Website
Founded Year
2004
Headcount
51 - 200 ( View All )
Specialties
Cell-based therapiescellular medicinesMesenchymal Lineage Adult Stem Cellsregenerative medicineCOVID-19Chronic Heart FailureGraft Versus Host DiseaseChronic Low Back PainRheumatoid Arthritis
Mesoblast Limited's Competitors
Employee Insights
Mesoblast Limited's Top Employees
Frequently Asked Questions Regarding Mesoblast Limited
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts